Citations (64)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Evelyn Hearne, Emanuele Amorim Alves, Marie Claire Van Hout & Jean-Paul C. Grund. (2017) Home Manufacture of Drugs: An Online Investigation and a Toxicological Reality Check of Online Discussions on Drug Chemistry. Journal of Psychoactive Drugs 49:4, pages 279-288.
Read now
Read now
Zsuzsa Kaló, Levente Móró, Zsolt Demetrovics & Katalin Felvinczi. (2017) A mixed-methods analysis of online NPS user discussion in Hungary. Drugs: Education, Prevention and Policy 24:4, pages 340-347.
Read now
Read now
Jim McVeigh, Jennifer Germain & Marie Claire Van Hout. (2017) 2,4-Dinitrophenol, the inferno drug: a netnographic study of user experiences in the quest for leanness. Journal of Substance Use 22:2, pages 131-138.
Read now
Read now
Evelyn Hearne & Marie Claire Van Hout. (2016) “Trip-Sitting” in the Black Hole: A Netnographic Study of Dissociation and Indigenous Harm Reduction. Journal of Psychoactive Drugs 48:4, pages 233-242.
Read now
Read now
Will Lawn, Rohan Borschmann, Angela Cottrell & Adam Winstock. (2016) Methoxetamine: prevalence of use in the USA and UK and associated urinary problems. Journal of Substance Use 21:2, pages 115-120.
Read now
Read now
Marie Claire Van Hout & Evelyn Hearne. (2015) “Vintage Meds”: A Netnographic Study of User Decision-Making, Home Preparation, and Consumptive Patterns of Laudanum. Substance Use & Misuse 50:5, pages 598-608.
Read now
Read now
Marie Claire Van Hout & Evelyn Hearne. (2015) “Word of Mouse”: Indigenous Harm Reduction and Online Consumerism of the Synthetic Compound Methoxphenidine. Journal of Psychoactive Drugs 47:1, pages 30-41.
Read now
Read now
Cynthia L. Arfken, Darlene Owens, Cheryl Madeja & Christina DeAngelis. (2014) Exploratory Comparative Study on the Diffusion of Synthetic Cannabinoids and Synthetic Cathinones. Journal of Psychoactive Drugs 46:5, pages 362-368.
Read now
Read now
Marie Claire Van Hout. (2014) An Internet Study of User’s Experiences of the Synthetic Cathinone 4-Methylethcathinone (4-MEC). Journal of Psychoactive Drugs 46:4, pages 273-286.
Read now
Read now
Articles from other publishers (55)
Romain Magny, Bruno Mégarbane, Lucie Chevillard, Emmanuel Roulland, Benoit Bardèche-Trystram, Véronique Dumestre-Toulet, Laurence Labat & Pascal Houzé. (2024) A combined toxicokinetic and metabolic approach to investigate deschloro-N-ethylketamine exposure in a multidrug user. Journal of Pharmaceutical and Biomedical Analysis 243, pages 116086.
Crossref
Crossref
Zack Blumenfeld, Kallol Bera, Eero Castrén & Henry A. Lester. (2023) Antidepressants enter cells, organelles, and membranes. Neuropsychopharmacology 49:1, pages 246-261.
Crossref
Crossref
Souleiman El Balkhi & Chadi Abbara. (2023) Designer Benzodiazepines: Effects, Toxicity, and Interactions. Therapeutic Drug Monitoring 45:4, pages 494-507.
Crossref
Crossref
Aeseul Kim, Sun Mi Gu, Haemiru Lee, Dong Eun Kim, Jin Tae Hong, Jaesuk Yun & Hye Jin Cha. (2023) Prenatal ketamine exposure impairs prepulse inhibition via arginine vasopressin receptor 1A-mediated GABAergic neuronal dysfunction in the striatum. Biomedicine & Pharmacotherapy 160, pages 114318.
Crossref
Crossref
Romain Pelletier, Brendan Le Daré, Diane Le Bouëdec, Angéline Kernalléguen, Pierre-Jean Ferron, Isabelle Morel & Thomas Gicquel. (2022) Arylcyclohexylamine Derivatives: Pharmacokinetic, Pharmacodynamic, Clinical and Forensic Aspects. International Journal of Molecular Sciences 23:24, pages 15574.
Crossref
Crossref
Ana Y. Simão, Mónica Antunes, Emanuel Cabral, Patrik Oliveira, Luana M. Rosendo, Ana Teresa Brinca, Estefânia Alves, Hernâni Marques, Tiago Rosado, Luís A. Passarinha, Maristela Andraus, Mário Barroso & Eugenia Gallardo. (2022) An Update on the Implications of New Psychoactive Substances in Public Health. International Journal of Environmental Research and Public Health 19:8, pages 4869.
Crossref
Crossref
Bronislav Jurásek, Silvie Rimpelová, Martin Babor, Jan Čejka, Vilém Bartůněk & Martin Kuchař. (2022) Intriguing Cytotoxicity of the Street Dissociative Anesthetic Methoxphenidine: Unexpected Impurities Spotted. International Journal of Molecular Sciences 23:4, pages 2083.
Crossref
Crossref
Mark D. Salter & Naren Gunja. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
381
414
.
Matteo Marti, Giuseppe Talani, Cristina Miliano, Sabrine Bilel, Francesca Biggio, Jessica Bratzu, Marco Diana, Maria Antonietta De Luca & Liana Fattore. (2021) New insights into methoxetamine mechanisms of action: Focus on serotonergic 5-HT2 receptors in pharmacological and behavioral effects in the rat. Experimental Neurology 345, pages 113836.
Crossref
Crossref
Michal Ordak, Aleksandra Zmysłowska, Miłosz Bielski, Daniel Rybak, Maja Tomaszewska, Katarzyna Wyszomierska, Aleksandra Kmiec, Natalia Garlicka, Maria Zalewska, Michal Zalewski, Tadeusz Nasierowski, Elzbieta Muszynska & Magdalena Bujalska-Zadrozny. (2021) Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports. Frontiers in Psychiatry 12.
Crossref
Crossref
Souleiman El Balkhi, Caroline Monchaud, Frédéric Herault, Hélène Géniaux & Franck Saint-Marcoux. (2020) Designer benzodiazepines’ pharmacological effects and potencies: How to find the information. Journal of Psychopharmacology 34:9, pages 1021-1029.
Crossref
Crossref
Anders Bork Davidsen, Marie Mardal, Niels Bjerre Holm, Anna Katrine Andreasen, Sys Stybe Johansen, Carolina Noble, Petur Dalsgaard & Kristian Linnet. (2020) Ketamine analogues: Comparative toxicokinetic in vitro–in vivo extrapolation and quantification of 2-fluorodeschloroketamine in forensic blood and hair samples. Journal of Pharmaceutical and Biomedical Analysis 180, pages 113049.
Crossref
Crossref
Zsuzsa Kaló, Szilvia Kassai, József Rácz & Marie Claire Van Hout. (2018) Synthetic Cannabinoids (SCs) in Metaphors: a Metaphorical Analysis of User Experiences of Synthetic Cannabinoids in Two Countries. International Journal of Mental Health and Addiction 18:1, pages 160-176.
Crossref
Crossref
Giulia Costa, MariaAntonietta De Luca, Gessica Piras, Jacopo Marongiu, Liana Fattore & Nicola Simola. (2020) Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies. Neural Regeneration Research 15:5, pages 802.
Crossref
Crossref
Giulia Costa, Marcello Serra, Nicholas Pintori, Maria Antonietta Casu, Mary Tresa Zanda, Daniela Murtas, Maria Antonietta De Luca, Nicola Simola & Liana Fattore. (2019) The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats. Neuropharmacology 144, pages 219-232.
Crossref
Crossref
Chrislean Jun Botanas, June Bryan de la Peña, Hee Jin Kim, Yong Sup Lee & Jae Hoon Cheong. (2019) Methoxetamine: A foe or friend?. Neurochemistry International 122, pages 1-7.
Crossref
Crossref
Karel James BouseKarel James Bouse. 2019. Neo-shamanism and Mental Health. Neo-shamanism and Mental Health
99
115
.
Andrea Ossato, Sabrine Bilel, Adolfo Gregori, Anna Talarico, Claudio Trapella, Rosa Maria Gaudio, Fabio De-Giorgio, Franco Tagliaro, Margherita Neri, Liana Fattore & Matteo Marti. (2018) Neurological, sensorimotor and cardiorespiratory alterations induced by methoxetamine, ketamine and phencyclidine in mice. Neuropharmacology 141, pages 167-180.
Crossref
Crossref
Michael D. Berquist, William S. Hyatt, Jonathan Bauer-Erickson, Brenda M. Gannon, Andrew P. Norwood & William E. Fantegrossi. (2018) Phencyclidine-like in vivo effects of methoxetamine in mice and rats. Neuropharmacology 134, pages 158-166.
Crossref
Crossref
Derek G. Waller & Anthony P. Sampson. 2018. Medical Pharmacology and Therapeutics. Medical Pharmacology and Therapeutics
675
688
.
James H. Ho & Paul I. Dargan. 2018. Critical Care Toxicology. Critical Care Toxicology
1
47
.
Torsten Passie & Simon D. Brandt. 2018. New Psychoactive Substances. New Psychoactive Substances
69
110
.
Jason Wallach & Simon D. Brandt. 2018. New Psychoactive Substances. New Psychoactive Substances
305
352
.
Frederik Bøhling. (2017) Psychedelic pleasures: An affective understanding of the joys of tripping. International Journal of Drug Policy 49, pages 133-143.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
Marie Claire Van Hout & Evelyn Hearne. (2016) User Experiences of Development of Dependence on the Synthetic Cannabinoids, 5f-AKB48 and 5F-PB-22, and Subsequent Withdrawal Syndromes. International Journal of Mental Health and Addiction 15:3, pages 565-579.
Crossref
Crossref
Joan M. Striebel, Emily E. Nelson & Raj K. Kalapatapu. (2017) “Being with a Buddha”: A Case Report of Methoxetamine Use in a United States Veteran with PTSD. Case Reports in Psychiatry 2017, pages 1-4.
Crossref
Crossref
James H. Ho & Paul I. Dargan. 2017. Critical Care Toxicology. Critical Care Toxicology
1439
1484
.
Mary T. Zanda, Paola Fadda, Cristiano Chiamulera, Walter Fratta & Liana Fattore. (2016) Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings. Behavioural Pharmacology 27:6, pages 489-496.
Crossref
Crossref
Kevin F. Maskell, Michael L. Bailey & S. Rutherfoord Rose. (2016) Self Medication with Methoxetamine as an Analgesic Resulting in Significant Toxicity. Pain Medicine 17:9, pages 1773-1775.
Crossref
Crossref
Rachel R. Horsley, Eva Lhotkova, Katerina Hajkova, Bronislav Jurasek, Martin Kuchar & Tomas Palenicek. (2016) Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue—Behavioural, pharmacokinetic and metabolic studies in the Wistar rat. Brain Research Bulletin 126, pages 102-110.
Crossref
Crossref
Anna Mutti, Sonia Aroni, Paola Fadda, Laura Padovani, Laura Mancini, Roberto Collu, Anna Lisa Muntoni, Liana Fattore & Cristiano Chiamulera. (2016) The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission. Psychopharmacology 233:12, pages 2241-2251.
Crossref
Crossref
Cristiano Chiamulera, Federica Armani, Anna Mutti & Liana Fattore. (2016) The ketamine analogue methoxetamine generalizes to ketamine discriminative stimulus in rats. Behavioural Pharmacology 27:2 and 3 - Special Issue, pages 204-210.
Crossref
Crossref
Adam L. Halberstadt, Natalia Slepak, James Hyun, Mahalah R. Buell & Susan B. Powell. (2016) The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents. Psychopharmacology 233:7, pages 1215-1225.
Crossref
Crossref
Adam R. Winstock, Will Lawn, Paolo Deluca & Rohan Borschmann. (2015)
Methoxetamine: An early report on the motivations for use, effect profile and prevalence of use in a
UK
clubbing sample
. Drug and Alcohol Review 35:2, pages 212-217.
Crossref
Crossref
Katerina Hajkova, Bronislav Jurasek, David Sykora, Tomas Palenicek, Petra Miksatkova & Martin Kuchar. (2015) Salting-out-assisted liquid–liquid extraction as a suitable approach for determination of methoxetamine in large sets of tissue samples. Analytical and Bioanalytical Chemistry 408:4, pages 1171-1181.
Crossref
Crossref
James H. Ho & Paul I. Dargan. 2016. Critical Care Toxicology. Critical Care Toxicology
1
46
.
Jolanta B. Zawilska & Dariusz Andrzejczak. (2015) Next generation of novel psychoactive substances on the horizon – A complex problem to face. Drug and Alcohol Dependence 157, pages 1-17.
Crossref
Crossref
James H. Ho, George P. Bailey, John R. H. Archer, Paul I. Dargan & David M. Wood. (2015) Ethylphenidate: availability, patterns of use, and acute effects of this novel psychoactive substance. European Journal of Clinical Pharmacology 71:10, pages 1185-1196.
Crossref
Crossref
Anders Ledberg. (2015) The interest in eight new psychoactive substances before and after scheduling. Drug and Alcohol Dependence 152, pages 73-78.
Crossref
Crossref
Stefania Chiappini, Hugh Claridge, John M. Corkery, Christine Goodair, Barbara Loi & Fabrizio Schifano. (2015) Methoxetamine‐related deaths in the UK: an overview. Human Psychopharmacology: Clinical and Experimental 30:4, pages 244-248.
Crossref
Crossref
Chrislean Jun Botanas, June Bryan de la Peña, Irene Joy dela Peña, Reinholdgher Tampus, Robin Yoon, Hee Jin Kim, Yong Sup Lee, Choon Gon Jang & Jae Hoon Cheong. (2015) Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: Evidence of its abuse potential. Pharmacology Biochemistry and Behavior 133, pages 31-36.
Crossref
Crossref
Agnieszka Wiesner, Aleksandra Tyl & Jolanta B. Zawilska. (2015) Metoksetamina – nowy związek psychoaktywny („dopalacz”) o silnym działaniu psychodysleptycznym. Alcoholism and Drug Addiction 28:2, pages 131-138.
Crossref
Crossref
Christophe SoussanAnette Kjellgren. (2015) “Chasing the High” – Experiences of Ethylphenidate as Described on International Internet Forums. Substance Abuse: Research and Treatment 9, pages SART.S22495.
Crossref
Crossref
Piotr Adamowicz & Dariusz Zuba. (2014) Fatal Intoxication with Methoxetamine. Journal of Forensic Sciences 60:s1.
Crossref
Crossref
Marie Claire Van Hout. (2015) Nod and wave: An Internet study of the codeine intoxication phenomenon. International Journal of Drug Policy 26:1, pages 67-77.
Crossref
Crossref
Rebecca Gale & Alison Hall. 2015. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
129
146
.
Jolanta B. Zawilska. (2014) Methoxetamine – a novel recreational drug with potent hallucinogenic properties. Toxicology Letters 230:3, pages 402-407.
Crossref
Crossref
Raymond J.M. Niesink & Tibor M. Brunt. (2015) Dissociatieve anesthesie: van ‘angel dust’ tot methoxetamine. Verslaving 11:4, pages 261-271.
Crossref
Crossref
Randy L. Luciano & Mark A. Perazella. (2014) Nephrotoxic effects of designer drugs: synthetic is not better!. Nature Reviews Nephrology 10:6, pages 314-324.
Crossref
Crossref
Christophe Soussan & Anette Kjellgren. (2017) The Flip Side of “Spice”: The Adverse Effects of Synthetic Cannabinoids as Discussed on a Swedish Internet Forum. Nordic Studies on Alcohol and Drugs 31:2, pages 207-220.
Crossref
Crossref
Marie Claire Van Hout. (2014) SMART: An Internet study of users experiences of synthetic tanning. Performance Enhancement & Health 3:1, pages 3-14.
Crossref
Crossref
Christophe Soussan & Anette Kjellgren. (2014) Harm reduction and knowledge exchange—a qualitative analysis of drug-related Internet discussion forums. Harm Reduction Journal 11:1, pages 25.
Crossref
Crossref
J.M. Marraffa. 2014. Encyclopedia of Toxicology. Encyclopedia of Toxicology
248
251
.
Anette KjellgrenHelena HenningssonChristophe Soussan. (2013) Fascination and Social Togetherness–-Discussions about Spice Smoking on a Swedish Internet Forum. Substance Abuse: Research and Treatment 7, pages SART.S13323.
Crossref
Crossref